Patent ID: 8790708

Claim:
A pharmaceutical composition comprising: (A) intragranular components: (a) about 35 weight percent of neratinib maleate measured in the amount of neratinib free base; (b) mannitol; (c) about 10.6 weight percent of microcrystalline cellulose; (d) about 3 weight percent of crospovidone; (e) about 2 weight percent of colloidal silicon dioxide; and (f) about 5 weight percent of povidone; and (B) extragranular components: (g) about 1.5 weight percent of microcrystalline cellulose; (h) about 2 weight percent of crospovidone; and (i) about 2 weight percent of magnesium stearate; and (C) a film-coating.